Total Payments
$253,797
2024 Payments
$876.83
Companies
27
Transactions
600
Medicare Patients
5,887
Medicare Billing
$826,181
Payment Breakdown by Category
Other$170,173 (67.1%)
Consulting$37,051 (14.6%)
Travel$32,817 (12.9%)
Food & Beverage$13,585 (5.4%)
Education$171.20 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $170,173 | 110 | 67.1% |
| Consulting Fee | $37,051 | 21 | 14.6% |
| Travel and Lodging | $32,817 | 167 | 12.9% |
| Food and Beverage | $13,585 | 293 | 5.4% |
| Education | $171.20 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $36,529 | 57 | $0 (2024) |
| Mylan Specialty L.P. | $32,179 | 72 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $27,994 | 61 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $26,029 | 41 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $25,369 | 68 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $18,238 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16,859 | 47 | $0 (2024) |
| SANOFI PASTEUR INC. | $15,206 | 29 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $11,797 | 33 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $9,073 | 16 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $876.83 | 44 | Insulet Corporation ($249.43) |
| 2023 | $144.38 | 8 | GlaxoSmithKline, LLC. ($40.14) |
| 2022 | $2,728 | 7 | AstraZeneca Pharmaceuticals LP ($1,884) |
| 2021 | $9,410 | 14 | Regeneron Healthcare Solutions, Inc. ($2,668) |
| 2020 | $14,206 | 36 | Mylan Specialty L.P. ($11,500) |
| 2019 | $56,459 | 122 | Mylan Specialty L.P. ($17,508) |
| 2018 | $42,534 | 85 | Sunovion Pharmaceuticals Inc. ($9,976) |
| 2017 | $127,439 | 284 | Novo Nordisk Inc ($33,864) |
All Payment Transactions
600 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Insulin Pump | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: PAIN | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: PAIN | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.11 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $88.25 | General |
| Category: Insulin Pump | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $30.29 | General |
| Category: Insulin Pump | ||||||
| 08/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $30.29 | General |
| Category: Insulin Pump | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: VACCINE | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: DIABETES | ||||||
| 07/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: PAIN | ||||||
| 07/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Obesity | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $41.18 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 831 | 3,977 | $504,396 | $136,895 |
| 2022 | 16 | 1,162 | 6,189 | $715,823 | $189,116 |
| 2021 | 24 | 1,853 | 9,526 | $770,222 | $265,574 |
| 2020 | 26 | 2,041 | 8,949 | $730,237 | $234,596 |
Total Patients
5,887
Total Services
28,641
Medicare Billing
$826,181
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 293 | 653 | $202,430 | $56,338 | 27.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 30 | 2,520 | $191,520 | $45,684 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 229 | $50,380 | $14,912 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $24,600 | $9,374 | 38.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 53 | $8,056 | $3,740 | 46.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 36 | 119 | $8,092 | $1,912 | 23.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 53 | $2,650 | $1,546 | 58.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 17 | 41 | $4,920 | $971.80 | 19.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 66 | 102 | $4,794 | $971.04 | 20.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 13 | 14 | $2,338 | $703.92 | 30.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 45 | $3,375 | $434.80 | 12.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 14 | 73 | $1,241 | $306.60 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 358 | 933 | $282,699 | $82,283 | 29.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 47 | 4,020 | $297,480 | $66,786 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 323 | $69,445 | $20,220 | 29.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 68 | 68 | $5,372 | $4,589 | 85.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 68 | 188 | $12,418 | $2,990 | 24.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $7,062 | $2,811 | 39.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 75 | 75 | $3,750 | $2,104 | 56.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 28 | 68 | $7,956 | $1,794 | 22.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 104 | 168 | $7,728 | $1,585 | 20.5% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 11 | 11 | $5,258 | $1,156 | 22.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 58 | 93 | $6,789 | $869.98 | 12.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 15 | 16 | $2,608 | $814.29 | 31.2% |
| 85610 | Blood test, clotting time | Office | 2022 | 18 | 120 | $1,920 | $508.79 | 26.5% |
About Dr. Douglas Kelling, MD
Dr. Douglas Kelling, MD is a Pulmonary Disease healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396717708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Kelling, MD has received a total of $253,797 in payments from pharmaceutical and medical device companies, with $876.83 received in 2024. These payments were reported across 600 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($170,173).
As a Medicare-enrolled provider, Kelling has provided services to 5,887 Medicare beneficiaries, totaling 28,641 services with total Medicare billing of $826,181. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine
- Location Concord, NC
- Active Since 02/02/2006
- Last Updated 07/15/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1396717708
Products in Payments
- Yupelri (Drug) $29,796
- ENTRESTO (Drug) $18,180
- DUPIXENT (Biological) $18,148
- BEVESPI AEROSPHERE (Drug) $15,954
- LONHALA MAGNAIR (Drug) $15,260
- FLUZONE HIGH-DOSE (Drug) $11,345
- UTIBRON (Drug) $10,102
- PRALUENT ALIROCUMAB INJECTION (Biological) $9,992
- Victoza (Drug) $9,655
- Repatha (Biological) $9,020
- Tresiba (Drug) $8,836
- CINQAIR (Drug) $8,457
- ELIQUIS (Drug) $8,320
- Ozempic (Drug) $7,244
- XARELTO (Drug) $6,486
- INVOKANA (Drug) $5,305
- FASENRA (Drug) $4,370
- JARDIANCE (Drug) $4,144
- FLUBLOK QUADRIVALENT (Drug) $3,860
- BREZTRI (Drug) $2,619
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Concord
John Hadley, M.d, M.D
Pulmonary Disease — Payments: $7,581
Pulmonary Disease $7,581
Dr. Meena Mehta, Md, MD
Pulmonary Disease — Payments: $3,984
Pulmonary Disease $3,984
Hiromi Takekuma, D.o, D.O
Pulmonary Disease — Payments: $1,254
Pulmonary Disease $1,254
Richard Kops, M.d, M.D
Pulmonary Disease — Payments: $558.43
Pulmonary Disease $558.43
Sahar Mansoor, Md, MD
Pulmonary Disease — Payments: $410.04
Pulmonary Disease $410.04
Neha Mehta, Do, DO
Pulmonary Disease — Payments: $113.28
Pulmonary Disease $113.28